What are the major species causing Malarial illness?
Malaria
Cause
* Caused by Plasmodium
* P. vivax → milder, m/c outside Africa
* P. falciparum
* P. ovale
* P. malariae
What are the risk factors for severe malaria?
Risk factors
1)=>Pregnancy
* ↑ mortality in mother and baby
2)=>Age
* <5 years in high transmission areas
* Any age in low transmission areas
3)=> Immunosuppression
* e.g. HIV
* Non-immune travellers to endemic areas
Clinical features of severe malaria
Poor prognostic signs of Malaria
Poor Prognostic Indicators
* Age <3 years
* Cerebral malaria
* Shock, MOF
*↑ Lactataemia
* ↓ Glycaemia
* Renal failure
* Severe anaemia
* Hyperparasitaemia
* CSF ↑ lactate / ↓ glucose
Laboratory findings in severe Malaria
Labs in severe malaria
* Metabolic acidosis
* ↑ Lactate
* Hypoglycaemia
* Renal impairment
* Severe normocytic anaemia
* Hyperparasitaemia (>10%)
* Haemoglobinuria
=>Jaundice common, but hepatic failure uncommon
=>Acidosis and hyperlactatemia Multifactorial:
* Tissue hypoxia
* Liver dysfunction
* Abnormal renal bicarb clearance
Differential Diagnosis
Define Cerebral malaria
=>Term used for altered conscious state associated with Falciparum malaria & Not attributable to other conditions, e.g.:
* Hypoglycaemia
* Seizures
* Sedative
* Non malarial causes
What is the pathophysiology of cerebral malaria?
5 Hypotheses
1). Cytoadherence
* Parasite-infested RBCs have a tendency to adhere to: Other non-infected RBCs &
Endothelium
* Leads to embedding in deep vascular beds–>Sequestration of parasitized RBCs-> clogging of cerebral capillaries
* Also results in escape from splenic clearance
2). Impaired cerebral perfusion and hypoxia–>
Sequestration, reduced erythrocyte deformability–> reduced microvascular flow–> hypoxia and metabolic stress rather than widespread tissue necrosis.
3). Cytokine-mediated synaptic dysfunction
4). Endothelial injury ->Neuronal injury from malarial toxins
5). Secondary insults–> Seizures, fever, hypoglycaemia, and intracranial HTN increase risk of neuronal injury
Describe the clinical features of cerebral malaria
Clinical Features
* Fever
* Headache, body ache
* Delirium
* Visual symptoms
* Intracranial hypertension
* Seizures
* Coma
* Abnormal tone & posturing
* Hypoglycaemia
* Acidosis
Diagnostic testing
Tt for Uncomplicated Plasmodium falciparum malaria
=>Combination therapy with ≥2 antimalarial drugs with independent modes of action recommended.
=>Recommended regimens
1). Artesunate + amodiaquine
* Artesunate 4 mg/kg
* Amodiaquine 10 mg/kg
* OD for 3 days
2)Artesunate + sulfadoxine–pyrimethamine
* Artesunate 4 mg/kg daily × 3 days
* Sulfadoxine–pyrimethamine–>One dose on day 1.
3). Artesunate + mefloquine
* Once a day for 3 days
=>If 1st-trimester pregnancy,
Quinine + clindamycin should be used
=>2nd & 3rd trimester → Artesunate-based combination therapy
=>Second line-> Quinine + Tetracycline
Thick & thin films
=>Thick films- detection of parasite
* Larger amount of blood examined
* Used for detection of parasite
=>Thin films->detection of morphology & density
* Used for detection of morphology
* Used to assess parasite density (count)
RDTs
&
PCR testing
Pros and Cons
1). Histidine-rich protein (specific for Plasmodium falciparum)->
* Good sensitivity & specificity
2). Parasite lactate dehydrogenase (LDH)
3). Aldolase
=>Limitations:
* Sensitivity ↓ as parasitic load ↓
* Cannot detect parasite load
* Less sensitive for vivax
=>PCR tests
* Rapid
* Expensive
Role of Exchange Transfusion in Malaria
Exchange transfusion
* Considered in severe malaria with:
* Parasite count >10%
* Children with sickle cell anaemia
* Persistent acidosis / MOF unresponsive to first-line therapy
* Helps by removing parasitised RBCs and circulating toxins
* No strong evidence in favour
Tt regimen for Complicated Falciparum Malaria
Complicated / Severe Plasmodium falciparum malaria
First-line
* Artesunate–>2.4 mg/kg IV
@ 0 hrs, 12 hrs, and 24 hrs
* Then once daily
* If parenteral artesunate not available–> Artemether
* Less preferably quinine
=>Parenteral antimalarials for initial 24 hrs, irrespective of whether patient can tolerate oral therapy, then oral therapy as per guidelines
Single agent IV for first 24 hrs foll. by combination therapy
Clinical points of note
=>Shock may be due to splenic rupture or GI bleed
=>Low threshold for dialysis
=>Quinine->Kills mature forms, not premature
* Will leave immature forms
=>Artesunate kills young and mature forms
**=>EvidenceCochrane review–>IV Artesunate reduces risk of death in both children and adults when Compared to Quinine
**